Chemical industry – Page 35
-
Business
Trump lays out plan to slash drug costs
White House strategy to reduce pharmaceutical prices faces backlash from the industry, which cautions against the ‘far-reaching’ proposals
-
Business
Takeda set to swallow Shire
Shire’s US revenue and rare diseases portfolio grab Japanese firm’s attention
-
Article
Are polymer medicines viable therapeutics?
Combining small-molecule medicines with polymers could offer big rewards for pharmaceutical researchers
-
Article
The dark side of chemical patents
Unloved, ignored and misunderstood but could all that change?
-
Feature
Understanding Alzheimer’s
After hundreds of failed drug candidates, James Mitchell Crow asks if this is the last roll of the dice for the amyloid theory of Alzheimer’s disease
-
Business
Big business computing
Chemical and oil firms are using supercomputers to improve every part of their operations. Angeli Mehta reports
-
Feature
3D printing in pharma
Nina Notman explores how 3D printing is carving out a niche for itself in the pharmaceutical industry
-
Business
Chemicals caught in the middle as tariffs loom
America’s chemicals and plastics industry stands to lose $5bn if US–China dispute escalates
-
Business
Deal protects world’s biggest selling drug from biosimilar erosion
AbbVie and Samsung Bioepis resolve patent litigation over arthritis drug Humira
-
Business
India creates national drugs database to address supply and quality issues
Regulatory body takes steps to reform how it manages and monitors pharmaceuticals
-
Business
Novartis’ $8.7bn AveXis deal shows gene therapy appeal
Acquisition indicates the value of potentially permanent cures for inherited diseases
-
Business
AkzoNobel sells off specialty chemicals arm in €10bn deal
Private equity firm Carlyle sees off several other bidders
-
Opinion
Will robots make you redundant?
Smart machines could soon outpace even the best organic chemist
-
Research
Solving the crystal maze
Workflow swaps gut feelings for data when designing continuous crystallisation processes
-
News
What you need to know about neonicotinoids
The latest on the concerns raised about the pesticides’ impact on bees
-
Business
Fit for repurpose
Drugs that can be used for new indications offer a potentially cheaper pathway – but only if the investors can recoup their costs
-
Whitepaper
A guide to searching and using Markush structures
Chemical patents are often very long and difficult to read. Markush searching can enable you to easily categorise and filter the information you need, giving you the insights that a paper sometimes cannot.
-
Feature
Cuba: socialism, cigars and biotech
Nina Notman learns how biotechnology could potentially overtake cigars as Cuba’s most famous export
-
News
Brexit analysis predicts chemical industry contraction
UK government forced to publish briefing that suggests production will fall by up to 16%